Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: United Kingdom Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20041
20064
20073
20081
20091
20101
20113
20121
20151
20166
20175
20192
20203
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene4
Eli Lilly and Company3
GlaxoSmithKline3
Hoffmann-La Roche3
Astellas Pharma Inc2
Bristol-Myers Squibb2
PharmaMar2
AbbVie1
AbbVie (prior sponsor, Abbott)1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma39
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms7
Ovarian Neoplasms5
Neoplasm Metastasis4
Breast Neoplasms3
Neoplasms3
Carcinoma, Hepatocellular2
Head and Neck Neoplasms2
Pancreatic Neoplasms2

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.